Alzheimer risk factors age and female sex induce cortical Aβ aggregation by raising extracellular zinc
暂无分享,去创建一个
Á. Hunya | A. Bush | P. Adlard | J. Kálmán | A. Takeda | V. Szegedi | Z. Datki | H. Tamano | Zita Galik-Olah | Livia Fulop | E. Jánosi-Mózes | Haruna Tamano | Ákos Hunya
[1] Li Liu,et al. Zinc transporters in Alzheimer’s disease , 2019, Molecular Brain.
[2] A. Palmer,et al. Intracellular Zn2+ transients modulate global gene expression in dissociated rat hippocampal neurons , 2019, Scientific Reports.
[3] L. Schmued,et al. High Contrast and Resolution Labeling of Amyloid Plaques in Tissue Sections from APP-PS1 Mice and Humans with Alzheimer’s Disease with the Zinc Chelator HQ-O: Practical and Theoretical Considerations , 2019, Current Alzheimer research.
[4] A. Bush,et al. Difference in ability for extracellular Zn2+ influx between human and rat amyloid β1-42 and its significance. , 2019, Neurotoxicology.
[5] Benjamin A. Logsdon,et al. Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age , 2019, Nature Communications.
[6] A. Bush,et al. Treating Alzheimer's disease by targeting iron , 2019, British journal of pharmacology.
[7] J. Schneider,et al. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology , 2019, Molecular Psychiatry.
[8] T. Kambe,et al. Zinc Transporter Proteins: A Review and a New View from Biochemistry , 2019, Zinc Signaling.
[9] A. Bush,et al. Targeting metals rescues the phenotype in an animal model of tauopathy. , 2018, Metallomics : integrated biometal science.
[10] E. Gouaux,et al. Mechanisms for Zinc and Proton Inhibition of the GluN1/GluN2A NMDA Receptor , 2018, Cell.
[11] C. Ballard,et al. Associations between ZnT3, tau pathology, agitation, and delusions in dementia , 2018, International journal of geriatric psychiatry.
[12] Imane Lejri,et al. Mitochondria, Estrogen and Female Brain Aging , 2018, Front. Aging Neurosci..
[13] Yun-Ru Chen,et al. Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease , 2018, Scientific Reports.
[14] C. Rowe,et al. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study , 2017, Alzheimer's & dementia.
[15] A. Bush,et al. Extracellular Zn2+ Is Essential for Amyloid β1–42-Induced Cognitive Decline in the Normal Brain and Its Rescue , 2017, The Journal of Neuroscience.
[16] Joana S. Ferreira,et al. Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses , 2017, eLife.
[17] A. Bush,et al. Metal chaperones prevent zinc-mediated cognitive decline , 2015, Neurobiology of Disease.
[18] S. Lippard,et al. Modulation of extrasynaptic NMDA receptors by synaptic and tonic zinc , 2015, Proceedings of the National Academy of Sciences.
[19] D. Aarsland,et al. Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia. , 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[20] A. Bush,et al. Amyloid β-Mediated Zn2+ Influx into Dentate Granule Cells Transiently Induces a Short-Term Cognitive Deficit , 2014, PloS one.
[21] Alan J. Thomas,et al. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment , 2014, Neurobiology of Aging.
[22] A. Bush,et al. A novel approach to rapidly prevent age-related cognitive decline , 2013, Aging cell.
[23] H. Gábor. Physiological factors could enhance amyloid-beta toxicity , 2013 .
[24] Á. Hunya,et al. A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays , 2012, Brain Research Bulletin.
[25] J. Hwang,et al. Alteration of the Cerebral Zinc Pool in a Mouse Model of Alzheimer Disease , 2012, Journal of neuropathology and experimental neurology.
[26] R. Palmiter,et al. Dependence of the histofluorescently reactive zinc pool on zinc transporter-3 in the normal brain , 2011, Brain Research.
[27] Á. Hunya,et al. A novel application of the fluorescent dye bis-ANS for labeling neurons in acute brain slices , 2011, Brain Research Bulletin.
[28] J. Buxbaum,et al. Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold , 2011, Molecular Neurodegeneration.
[29] A. Bush,et al. Presenilins Promote the Cellular Uptake of Copper and Zinc and Maintain Copper Chaperone of SOD1-dependent Copper/Zinc Superoxide Dismutase Activity* , 2011, The Journal of Biological Chemistry.
[30] K. Blennow,et al. PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. , 2010, Journal of Alzheimer's disease : JAD.
[31] A. Bush,et al. Cognitive Loss in Zinc Transporter-3 Knock-Out Mice: A Phenocopy for the Synaptic and Memory Deficits of Alzheimer's Disease? , 2010, The Journal of Neuroscience.
[32] J. Hellemans,et al. ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain , 2009, Molecular Neurodegeneration.
[33] A. Bush,et al. Zinc in the physiology and pathology of the CNS , 2009, Nature Reviews Neuroscience.
[34] R. Metherate,et al. A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses , 2009, The Journal of Neuroscience.
[35] K. Blennow,et al. Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial , 2008, The Lancet Neurology.
[36] C. Shuttleworth,et al. Zn2+ Influx Is Critical for Some Forms of Spreading Depression in Brain Slices , 2008, The Journal of Neuroscience.
[37] C. Masters,et al. Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ , 2008, Neuron.
[38] Charles P. Fontaine,et al. Insights into Zn2+ homeostasis in neurons from experimental and modeling studies. , 2008, American journal of physiology. Cell physiology.
[39] M. Stoltenberg,et al. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency , 2007, Neuroscience.
[40] Á. Hunya,et al. A novel and simple fluorescence method for the measurement of presynaptic vesicular zinc release in acute hippocampal slices with a fluorescence plate reader , 2007, Brain Research Bulletin.
[41] E. Krause,et al. Depsipeptide methodology for solid-phase peptide synthesis: circumventing side reactions and development of an automated technique via depsidipeptide units. , 2006, The Journal of organic chemistry.
[42] Yaping Zeng,et al. Synaptic release of zinc from brain slices: Factors governing release, imaging, and accurate calculation of concentration , 2006, Journal of Neuroscience Methods.
[43] L. Juliano,et al. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. , 2005, The Journal of biological chemistry.
[44] Y. Kiso,et al. The ‘O‐acyl isopeptide method’ for the synthesis of difficult sequence‐containing peptides: application to the synthesis of Alzheimer's disease‐related amyloid β peptide (Aβ) 1–42 , 2005, Journal of peptide science : an official publication of the European Peptide Society.
[45] J. Troncoso,et al. Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques , 2005, Histochemistry and Cell Biology.
[46] A. Bush,et al. The neurobiology of zinc in health and disease , 2005, Nature Reviews Neuroscience.
[47] A. Craig,et al. NMDA Receptor Activation Mediates Copper Homeostasis in Hippocampal Neurons , 2005, The Journal of Neuroscience.
[48] M. Bennett,et al. Late Calcium EDTA Rescues Hippocampal CA1 Neurons from Global Ischemia-Induced Death , 2004, The Journal of Neuroscience.
[49] J. Koh,et al. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice , 2004, Neurobiology of Aging.
[50] H. Braak,et al. The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism , 2004, Annals of the New York Academy of Sciences.
[51] R. Palmiter,et al. Neuronal Zinc Exchange with the Blood Vessel Wall Promotes Cerebral Amyloid Angiopathy in an Animal Model of Alzheimer's Disease , 2004, The Journal of Neuroscience.
[52] R. Palmiter,et al. Estrogen Decreases Zinc Transporter 3 Expression and Synaptic Vesicle Zinc Levels in Mouse Brain* , 2004, Journal of Biological Chemistry.
[53] A. Mackinnon,et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.
[54] D. Holtzman,et al. In Vivo Assessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life , 2003, The Journal of Neuroscience.
[55] C. Finch,et al. Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[56] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[57] H. Levine. 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonate: report on non-β-sheet conformers of Alzheimer's peptide β(1-40) , 2002 .
[58] Jae-Young Koh,et al. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[59] H. Levine. 4,4(')-Dianilino-1,1(')-binaphthyl-5,5(')-disulfonate: report on non-beta-sheet conformers of Alzheimer's peptide beta(1-40). , 2002, Archives of biochemistry and biophysics.
[60] J. Sarvey,et al. Induction of Mossy Fiber→CA3 Long-Term Potentiation Requires Translocation of Synaptically Released Zn2+ , 2001, The Journal of Neuroscience.
[61] C. Masters,et al. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.
[62] F. Bian,et al. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. , 2001, The American journal of pathology.
[63] Xudong Huang,et al. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.
[64] C. Ackerley,et al. Endogenous Zn2+ is required for the induction of long‐term potentiation at rat hippocampal mossy fiber‐CA3 synapses , 2000, Synapse.
[65] Xudong Huang,et al. Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.
[66] R. Colvin,et al. Zinc transport in the brain: routes of zinc influx and efflux in neurons. , 2000, The Journal of nutrition.
[67] Sang Won Suh,et al. Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains , 2000, Brain Research.
[68] M. Smith,et al. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. , 2000, The Journal of biological chemistry.
[69] C. Masters,et al. Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.
[70] C. Barrow,et al. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. , 1999, Biochemistry.
[71] Jae-Young Koh,et al. Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice , 1999, The Journal of Neuroscience.
[72] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[73] Xudong Huang,et al. Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.
[74] Yong Y. He,et al. The Role of Zinc in Selective Neuronal Death After Transient Global Cerebral Ischemia , 1996, Science.
[75] T. J. Teyler,et al. Making the best of brain slices; comparing preparative methods , 1995, Journal of Neuroscience Methods.
[76] R. Palmiter,et al. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. , 1995, The EMBO journal.
[77] C. Masters,et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.
[78] M. Mattson,et al. Growth Factors Prevent Mitochondrial Dysfunction, Loss of Calcium Homeostasis, and Cell Injury, but Not ATP Depletion in Hippocampal Neurons Deprived of Glucose , 1993, Experimental Neurology.
[79] M. Mayer,et al. The action of zinc on synaptic transmission and neuronal excitability in cultures of mouse hippocampus. , 1989, The Journal of physiology.
[80] R. Martins,et al. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease , 1988, Neurology.
[81] D. Choi,et al. Zinc neurotoxicity in cortical cell culture , 1988, Neuroscience.
[82] M. Mayer,et al. Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons , 1987, Nature.
[83] C. Cotman,et al. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease , 1986, Brain Research.
[84] G. A. Howell,et al. Stimulation-induced uptake and release of zinc in hippocampal slices , 1984, Nature.